The Government of Ontario has unveiled the next phase of its life sciences strategy and announced a $146M investment in the sector. The strategy aims to solidify the province as a leader in biomanufacturing and health sciences by focusing on four key efforts: advancing research and development, unlocking new streams of capital, supporting the existing ecosystem, and adopting a culture of innovation. Up to $46M will go to the Ontario Biosciences Research Infrastructure Fund to boost research capacity at postsecondary institutions and affiliated research hospitals, $15M will support a new wet labs program, and $5M will support Clinical Trials Ontario’s QuickSTART Initiative.
ON
| Global News
